Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)

Yvonne Roelofsen, Steven H Hendriks, Floor Sieverink, Michael van Vugt, Kornelis Jj van Hateren, Frank J Snoek, Maartje de Wit, Rijk Ob Gans, Klaas H Groenier, Julia Ewc van Gemert-Pijnen, Nanne Kleefstra, Henk Jg Bilo, Yvonne Roelofsen, Steven H Hendriks, Floor Sieverink, Michael van Vugt, Kornelis Jj van Hateren, Frank J Snoek, Maartje de Wit, Rijk Ob Gans, Klaas H Groenier, Julia Ewc van Gemert-Pijnen, Nanne Kleefstra, Henk Jg Bilo

Abstract

Trial registration: NCT01570140.

Background: Due to ongoing rise in need for care for people with chronic diseases and lagging increase in number of care providers, alternative forms of care provision and self-management support are needed. Empowering patients through an online care platform could help to improve patients' self-management and reduce the burden on the healthcare system.

Methods: Access to laboratory results and educational modules on diabetes will be offered through a platform for subjects with type 2 diabetes mellitus treated in primary care. Differences in socio-demographic and clinical characteristics between subjects expressing interest vs. disinterest to use the platform will be explored. Platform usage will be tracked and compared. Patient satisfaction and quality of life will be measured by validated questionnaires and economic analyses will be performed.

Discussion: This study is designed to assess the feasibility of use of an online platform in routine primary healthcare for subjects with type 2 diabetes mellitus in the Netherlands, and to study effects of use of the platform on treatment satisfaction, quality of life and clinical parameters. Although providing access to a online platform is not a novel intervention, usage and effects have not yet been studied in this patient population.

Figures

Figure 1
Figure 1
Patient flow.
Figure 2
Figure 2
RCT nested in e-VitaDM study.
Figure 3
Figure 3
Individual timeline.

References

    1. Baan CA, van Baal PH, der Bruggen MA J-v, Verkley H, Poos MJ, Hoogenveen RT, Schoemaker CG. Diabetes mellitus in Nederland: schatting van de huidige ziektelast en prognose voor 2025. Nederlands Tijdschrift Voor Geneeskunde. 2009;153:1052–1058.
    1. Bilo HJG, Houweling ST. Toename van het aantal mensen met diabetes mellitus: noodzaak van een deltaplan. Nederlands Tijdschrift Voor Geneeskunde. 2009;153:1048–1049.
    1. Tang PC, Ash JS, Bates DW, Overhage JM, Sands DZ. Personal health records: definitions, benefits, and strategies for overcoming barriers to adoption. J Am Med Inform Assoc. 2006;13:121–126. doi: 10.1197/jamia.M2025.
    1. Bower P, Cartwright M, Hirani SP, Barlow J, Hendy J, Knapp M, Henderson C, Rogers A, Sanders C, Bardsley M, Steventon A, Fitzpatrick R, Doll H, Newman S. A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the whole systems demonstrator cluster randomised trial. BMC Health Serv Res. 2011;11:184. doi: 10.1186/1472-6963-11-184.
    1. Kennedy A, Bower P, Reeves D, Blakeman T, Bowen R, Chew-Graham C, Eden M, Fullwood C, Gaffney H, Gardner C, Lee V, Morris R, Protheroe J, Richardson G, Sanders C, Swallow A, Thompson D, Rogers A. on behalf of the Salford National Institute for Health Research Gastrointestinal programme Grant Research Group. Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial. BMJ. 2013;346:f2882–f2882. doi: 10.1136/bmj.f2882.
    1. Henderson C, Knapp M, Fernández J-L, Beecham J, Hirani SP, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P, Doll H, Fitzpatrick R, Steventon A, Bardsley M, Hendy J, Newman SP. Whole System Demonstrator Evaluation Team. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ. 2013;346:f1035. doi: 10.1136/bmj.f1035.
    1. Van der Bruggen JMAM, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, Feskens EJM, Baan CA. Cost-effectiveness of lifestyle modification in diabetic patients. Diabetes Care. 2009;32:1453–1458. doi: 10.2337/dc09-0363.
    1. Lin JSJS, O’Connor EE, Whitlock EPEP, Beil TLTL, Zuber SPSP, Perdue LALA, Plaut DD, Lutz KK. Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease in Adults: Update of the Evidence for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010.
    1. Fonda SJ, McMahon GT, Gomes HE, Hickson S, Conlin PR. Changes in diabetes distress related to participation in an internet-based diabetes care management program and glycemic Control. J Diabetes Sci Technol. 2009;3:117–124. doi: 10.1177/193229680900300113.
    1. Kleefstra N, Landman GWD, Houweling ST, Ubink-Veltmaat LJ, Logtenberg SJJ, Meyboom-de Jong B, Coyne JC, Groenier KH, Bilo HJG. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4) Diabetes Care. 2008;31:932–933. doi: 10.2337/dc07-2072.
    1. Landman GWD, van Hateren KJJ, Kleefstra N, Groenier KH, Gans ROB, Bilo HJG. Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18) Diabetes Care. 2010;33:2378–2382. doi: 10.2337/dc10-0979.
    1. Van Vugt M, de Wit M, Hendriks SH, Roelofsen Y, Bilo HJ, Snoek FJ. Web-based self-management with and without coaching for type 2 diabetes patients in primary care: design of a randomized controlled trial. BMC Endocr Disord. 2013;13:53. doi: 10.1186/1472-6823-13-53.
    1. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20:1727–1736. doi: 10.1007/s11136-011-9903-x.
    1. Bech P, Olsen LR, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 mental health subscale and the WHO-five well-being scale. Int J Methods Psychiatr Res. 2003;12:85–91. doi: 10.1002/mpr.145.
    1. McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, Kokoszka A, Matthews D, Pibernik-Okanović M, Rodríguez-Saldaña J, de Wit M, Snoek FJ. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia. 2010;53:66–69. doi: 10.1007/s00125-009-1559-5.
    1. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Dia Care. 2000;23:943–950. doi: 10.2337/diacare.23.7.943.
    1. Grol R, Wensing M, Mainz J, Jung HP, Ferreira P, Hearnshaw H, Hjortdahl P, Olesen F, Reis S, Ribacke M, Szecsenyi J. Patients in Europe evaluate general practice care: an international comparison. Br J Gen Pract. 2000;50:882–887.
    1. The EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Pol. 1990;16:199–208.
    1. Bilo HJG, Logtenberg SJJ, Joosten H, Groenier KH, Ubink-Veltmaat LJ, Kleefstra N. Modification of diet in renal disease and Cockcroft-Gault formulas do not predict mortality (ZODIAC-6) Diabet Med. 2009;26:478–482. doi: 10.1111/j.1464-5491.2009.02709.x.
    1. Drion I, Kleefstra N, Landman GWD, Alkhalaf A, Struck J, Groenier KH, Bakker SJL, Bilo HJG. Plasma COOH-Terminal Proendothelin-1: a marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29) Diabetes Care. 2012;35:2354–2358. doi: 10.2337/dc11-2526.
    1. van Hateren KJJ, Drion I, Kleefstra N, Groenier KH, Houweling ST, van der Meer K, Bilo HJG. A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19) BMJ Open. 2012;2:E001387.
    1. Landman GWD, Kleefstra N, van Hateren KJJ, Groenier KH, Gans ROB, Bilo HJG. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010;33:322–326. doi: 10.2337/dc09-1380.
    1. Lutgers HL, Gerrits EG, Sluiter WJ, Ubink-Veltmaat LJ, Landman GWD, Links TP, Gans ROB, Smit AJ, Bilo HJG. Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10) PLoS One. 2009;4:e6817. doi: 10.1371/journal.pone.0006817.
    1. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1) Eur J Epidemiol. 2003;18:793–800.
    1. Van Hateren KJJ, Landman GWD, Kleefstra N, Logtenberg SJJ, Groenier KH, Kamper AM, Houweling ST, Bilo HJG. The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13) PLoS ONE. 2009;4:e8464. doi: 10.1371/journal.pone.0008464.
    1. Kelders SM, Bohlmeijer ET, Van Gemert-Pijnen JE. Participants, usage, and use patterns of a web-based intervention for the prevention of depression within a randomized controlled trial. J Med Internet Res. 2013;15:e172. doi: 10.2196/jmir.2258.
    1. Gosling SD, Rentfrow PJ, Swann WB. A very brief measure of the Big-Five personality domains. J Res Pers. 2003;37:504–528. doi: 10.1016/S0092-6566(03)00046-1.
    1. Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40:1918–1930. doi: 10.1111/j.1475-6773.2005.00438.x.
    1. Zaichkowsky JL. The personal involvement inventory: reduction, revision, and application to advertising. J Advert. 1994;23:59–70.
    1. Van Velsen LS. Doctoral dissertation: User-centered design for personalization. Enschede: University of Twente; 2011.
    1. Kelders SM. Doctoral dissertation: Understanding adherence to web-based interventions. Enschede: University of Twente; 2012.
    1. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532. doi: 10.1007/s11136-004-7713-0.
    1. Greenhalgh T, Hinder S, Stramer K, Bratan T, Russell J. Adoption, non-adoption, and abandonment of a personal electronic health record: case study of HealthSpace. BMJ. 2010;341:c5814–c5814. doi: 10.1136/bmj.c5814.
    1. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Fitzpatrick R, Hendy J, Newman S. Whole System Demonstrator Evaluation Team. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344:e3874. doi: 10.1136/bmj.e3874.
    1. Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, Rogers A, Sanders C, Fitzpatrick R, Barlow J, Newman SP. Whole Systems Demonstrator Evaluation Team. Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial. BMJ. 2013;346:f653. doi: 10.1136/bmj.f653.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe